Elisabetta Leo
7PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.Anna D Staniszewska, Domenic Pilger, Sonja J Gill
|Mar 30, 2023
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.Giulia Dellavedova, Alessandra Decio, Laura Formenti
|Mar 27, 2023
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.Kunzah Jamal, Alessandro Galbiati, Joshua Armenia
|Nov 10, 2022
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305.Krista Kinneer, Philipp Wortmann, Zachary A Cooper
|Aug 05, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper.Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill
|Oct 19, 2021
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.Sophie E Willis, Claudia Winkler, Martine P Roudier
Pageof 2
Frequent Collaborators
4 joint publications
Anna D Staniszewska
3 joint publications
Mark J O'Connor
3 joint publications
Kunzah Jamal
3 joint publications
Giuditta Illuzzi
2 joint publications
Claudia Winkler
2 joint publications
Stephen Fawell
2 joint publications
Sonja J Gill
2 joint publications
Andy Pike
2 joint publications
Lisa McWilliams
2 joint publications
Susan E Critchlow
